Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Skin Diseases × exemestane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 186 Neoplasm Metastasis 19 Neoplasms 6 Breast Neoplasms, Male 6 Ovarian Neoplasms 4 Breast Diseases 4 Obesity 3 Carcinoma, Intraductal, Noninfiltrating 3 Breast Carcinoma In Situ 3 Breast Cancer Metastatic 3 Recurrence 2 Prostatic Neoplasms 2 Multiple Endocrine Neoplasia Type 1 2 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Bulbo-Spinal Atrophy, X-Linked 2 Arthralgia 2 Advanced Breast Cancer 2 Vitamin D Deficiency 1 Uterine Cervical Neoplasms 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sleep Wake Disorders 1 Skin Diseases 1 Sexuality 1 Primary Breast Cancer ER+ve 1 Premenopausal Breast Cancer 1 Post Menopausal Women With Early Breast Cancer 1

Interventions

binimetinib 2 Watchful Waiting 2 Aminolevulinic Acid 2 palbociclib 1 methyl 5-aminolevulinate 1 ipatasertib 1 exemestane 1 encorafenib 1 baricitinib 1 atezolizumab 1 Vemurafenib 1 VP-102 1 Spironolactone 1 Sodium Chloride 1 Radiotherapy 1 Radiation 1 Photochemotherapy 1 Paclitaxel 1 Low-Level Light Therapy 1 Leuprolide 1 Gonadotropin-Releasing Hormone 1 Everolimus 1 Equipment and Supplies 1 Docetaxel 1 Dacarbazine 1 Cetuximab 1 Capecitabine 1 Cantharidin 1 Botulinum Toxins, Type A 1 BF-200 ALA 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01743560 2019-07-18

4EVERUK

Novartis

Phase 4 Completed

52 enrolled 16 charts

Breast Diseases, Breast Neoplasms, Neoplasms, Skin Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡